3-iodobenzylguanidine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, H; Matsuo, H; Nagashima, K; Nishida, H; Nishigaki, K; Noda, T; Takatsu, H; Wada, H; Watanabe, S | 1 |
| Fujiwara, H; Maekawa, N; Saito, K; Takatsu, H; Takemura, M; Wada, H | 1 |
| Fukuda, T; Fukumitsu, N; Kajiyama, S; Kiyono, Y; Saji, H; Suzuki, M | 1 |
| Fukuda, T; Fukumitsu, N; Kiyono, Y; Suzuki, M | 1 |
4 other study(ies) available for 3-iodobenzylguanidine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-Iodobenzylguanidine; Aged; Animals; Autonomic Nervous System Diseases; Case-Control Studies; Dopamine Agents; Female; Heart; Humans; Iodine Radioisotopes; Male; Mice; Mice, Inbred C57BL; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Time Factors | 2000 |
Significant reduction of 125 I-meta-iodobenzylguanidine accumulation directly caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a toxic agent for inducing experimental Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-Iodobenzylguanidine; Animals; Cells, Cultured; Desipramine; Dopamine Agents; Heart; Iodine Radioisotopes; Mice; Mice, Inbred C57BL; Myocardium; Neurons; Parkinsonian Disorders; PC12 Cells; Radionuclide Imaging; Rats | 2002 |
Reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-Iodobenzylguanidine; Animals; Dose-Response Relationship, Drug; Heart; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Myocardium; Norepinephrine Plasma Membrane Transport Proteins; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2006 |
Multipoint analysis of reduced (125)I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-Iodobenzylguanidine; Animals; Dopamine; Mice; Myocardium; Neostriatum; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Parkinson Disease; Time Factors; Tyrosine | 2009 |